Skip to Content
US Videos

Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.

Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?
Mentioned: , , , , , ,

Matt Coffina: For Morningstar StockInvestor, I'm Matt Coffina. I'm joined today by Damien Conover, who is the director of our health-care team. We are going to talk about pharmaceutical firms' pipelines. Damien, thanks for joining me.

Damien Conover: Matt, thanks for having me.

To view this article, become a Morningstar Basic member.

Register for Free

Matthew Coffina has a position in the following securities mentioned above: NVS, ABT, ESRX. Find out about Morningstar’s editorial policies.